On a Downhill Cycle

A doping scandal forces the Tour de France to wrestle with a champion's legacy and its own future

This year's Tour de France, which began on Saturday, is a prodigious test. Not just for the riders who climb, sprint and sweat their way along the three-week, 2,270-mile journey across the Alps and countryside. It's also a prodigious test for cycling's future. After seven straight victories, Lance Armstrong is no longer competing. Yet his legacy of success--coupled with fresh allegations of his wrongdoing--is casting a shadow over the start of this year's already chaotic race.

Critics, particularly in France, have long accused Armstrong, a cancer survivor, of needing drugs to win his titles. Adding fuel to that fire is recent...

Want the full story?

Subscribe Now

Subscribe
Subscribe

Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on TIME.com

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!